The Use of the Drospirenone 4 mg-Only Pill in Overweight and Obese Women with Polyendocrine Metabolic Ovarian Syndrome: A Retrospective Cohort Study. [PDF]
Hofer K +6 more
europepmc +1 more source
Follicular development impairment in polyendocrine metabolic ovarian syndrome: multidimensional pathophysiological networks and frontier therapeutic targets. [PDF]
Jia Q +5 more
europepmc +1 more source
Clinical, Metabolic and Hormonal Overlap Between Nonclassic Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome: An Exploratory Study. [PDF]
Yavuz A +3 more
europepmc +1 more source
Metabolic dysfunction in women with PCOS is more closely linked to BMI than to hyperandrogenism. [PDF]
Naderi P +6 more
europepmc +1 more source
Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making. [PDF]
Peng H, Jiang J, Wang Z, Wang W.
europepmc +1 more source
An unusual cause of hyperandrogenism.
Wendker-van Wattum, M. +4 more
openaire +2 more sources
Steroid Cell Tumor of the Ovary Presenting With Postmenopausal Bleeding and Hyperandrogenism: A Case Report. [PDF]
Mahurkar S, Surendran S, Cherian J.
europepmc +1 more source
The role of intestinal microbial metabolites in polycystic ovary syndrome: mechanistic insights and intervention prospects. [PDF]
Gao Y, Fan L, Ma R, Wu L.
europepmc +1 more source
Integrative Network View of PCOS: Organ Crosstalk Driven by the Hyperandrogenemia-Insulin Resistance-Inflammation Triad. [PDF]
Luo Z +9 more
europepmc +1 more source
Serum biomarkers for the diagnosis and management of adolescent polyendocrine metabolic ovarian syndrome: a systematic review and meta-analysis. [PDF]
Shi Y +4 more
europepmc +1 more source

